This move is archived. Current quotes and coverage live on the stock page.
Get WEED alerts:
Despite a surge in medical marijuana sales, Canopy Growth Corp's stock is struggling to maintain momentum.
Canopy Growth Corp (WEED.TO) saw a decline of 2.82% in the last trading session, closing at CA$1.38. This drop is surprising given the positive news about its medical marijuana segment, which has shown significant growth.
Advertisement
Canopy Growth Corp
WEED.TO
WEED.TO
Canopy Growth Corp
WealthAwesomeMarket cap
$661.03M
52W high
$3.28
52W low
$1.18
1W change
-4.14%
Beta
2.41
Analyst Price Targets
Based on analyst covering WEED
Wall Street analysts forecast WEED stock price to rise 45.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+45.3% Upside
Current Price
C$1.39
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
39.8%
Annualized
90-Day Vol
58.0%
Annualized
Trend (90d)
-32.0%
Annualized drift
90d Mean
C$1.24
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$1.34 | C$1.17 โ C$1.54 |
| 60 trading days | C$1.29 | C$1.06 โ C$1.56 |
| 90 trading days | C$1.24 | C$0.98 โ C$1.57 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should weigh the mixed performance across Canopy Growth's business segments and consider its recent financial challenges before making any investment decisions.
Canopy Growth Corp's stock drops 2.82% in one day.
Even with a 68% rise in international cannabis sales, overall revenue growth is being held back by supply chain issues and declining performance in key areas.
Bull case
The 27% increase in medical marijuana sales shows strong demand in the medical sector, which could lay the groundwork for future growth.
Bear case
However, the mixed results, especially in the recreational segment and declining gross margins, suggest that Canopy Growth's recovery might be tougher than expected.
Advertisement
Mixed Signals from Canopy Growth
Canopy Growth's recent performance highlights a stark contrast between its medical and recreational marijuana segments. While medical sales surged by 27% in the last fiscal year, the recreational segment's growth has stagnated, with only a 1% increase in the fourth quarter. This inconsistency raises questions about the company's ability to sustain momentum across its diverse business lines.
Financial Struggles Persist
Despite some positive signs, Canopy Growth continues to face significant financial challenges. The company's gross margin has declined, and it has reported negative earnings for over a decade. Investors should be cautious, as the recent recapitalization efforts indicate that the company is still struggling with its financial health. The overall outlook remains uncertain, making it a risky bet for potential investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
